Microsurgery

ZEISS Donates New Lab Equipment for BioBus STEM Outreach Programs at Northeastern University

Retrieved on: 
Monday, June 27, 2022
Science, Greater Boston, Research, M.A, College, Student, Ophthalmology, BioBus, Microscopy, Foundation, National Institute of Metrology Standardization and Industrial Quality, Curriculum, Industry, Carl-Zeiss-Stiftung, Health, Consumer, ZEISS, STEREO, K-12, Carl Zeiss AG, Awareness, Smart products, Partnership, Investment, STEM, Technology, Organization, Discovery, Light, Solution, Microsurgery, Thought, Education, Tutoring, Microscope, Pharmaceutical industry, Northeastern University

WHITE PLAINS, N.Y., June 27, 2022 /PRNewswire/ -- A class of high schoolers from Boston Green Academy cuts the ribbon on a new opportunity for students in the Greater Boston metropolitan area to experience scientific research adjacent to a fully functioning lab.

Key Points: 
  • BioBus developed and provides a broad STEM education curriculum, Northeastern University provided lab space and access to working scientists, and ZEISS Microscopy provided state-of-the-art microscopes.
  • Visiting a lab and using this equipment alongside professional scientists expands our students' awareness of what being a scientist looks like."
  • ZEISS Microscopy installed four Axiolab 5 microscopes and four SteREO Discovery.V8 Fluorescence Microscope Systems for use in the BioBus lab introductions.
  • The lab space in Northeastern University is in the same room as an active research environment.

Dr. Ryan Neinstein Announces Trailblazing Hire of Dr. Anna Steve at Neinstein Plastic Surgery

Retrieved on: 
Friday, June 24, 2022
PRS, Canadian Medical Association, CMA, American Society of Plastic Surgeons, Plastic, University, Patient, Plastic and Reconstructive Surgery, Blog, Population, Breast implant, Movement, University of Manitoba, Culture, Society, Microsurgery, Medical device, Dentistry, New York University

NEW YORK, June 24, 2022 /PRNewswire/ -- Neinstein Plastic Surgery is proud to announce that in July 2022, Dr. Anna Steve will be bringing fresh intellectual firepower to the growing surgical team at Neinstein Plastic Surgery.

Key Points: 
  • NEW YORK, June 24, 2022 /PRNewswire/ -- Neinstein Plastic Surgery is proud to announce that in July 2022, Dr. Anna Steve will be bringing fresh intellectual firepower to the growing surgical team at Neinstein Plastic Surgery.
  • Dr. Steve has contributed to several medical journal articles, concentrating on plastic and reconstructive surgery.
  • After relocating to New York City, Dr. Steve spent two years receiving subspecialty plastic surgery training at New York University, where she specialized in microsurgery and breast reconstruction surgery.
  • Dr. Neinstein has created a culture at Neinstein Plastic Surgery of lifelong learners with dynamic diversity.

ZEISS Microscopy Partners with LabCentral to Support Biotech Research Start-ups in the Boston, USA area

Retrieved on: 
Monday, June 6, 2022
Science, Microsurgery, Carl Zeiss AG, Smart products, Research, ZEISS, Deep learning, Microscopy, Consumer, AI, Partnership, Education, Solution, LabCentral, Maintenance, Investment, Ophthalmology, Carl-Zeiss-Stiftung, Technology, Health, Foundation, Industry, Drug discovery, Tissue, National Institute of Metrology Standardization and Industrial Quality, Light, Microscope, Pharmaceutical industry

WHITE PLAINS, N.Y., June 6, 2022 /PRNewswire/ -- ZEISS Microscopy announces a strategic partnership with LabCentral, a non-profit company founded in 2013 as a launchpad for promising biotech start-ups. ZEISS will provide access to key life science microscopy innovations for imaging and analysis solutions to researchers in LabCentral's 225,000 sq. ft. footprint in Cambridge, Massachusetts, USA.

Key Points: 
  • ZEISS will provide access to key life science microscopy innovations for imaging and analysis solutions to researchers in LabCentral's 225,000 sq.
  • When researchers sign on with LabCentral, they will be provided bench space and immediate access to cutting edge technology, including ZEISS instrumentation.
  • ZEISS Research Microscopy Solutions is the world's only one-stop manufacturer of light, electron, X-ray and ion microscope systems and offers solutions for correlative microscopy.
  • ZEISS Research Microscopy Solutions is part of the Industrial Quality & Research segment.

"Industrial Quality Solutions" Signifies More than Just a Name Change for ZEISS

Retrieved on: 
Wednesday, June 1, 2022
Science, Microsurgery, Carl Zeiss AG, Smart products, Research, LLC, ZEISS, Aircraft, Consumer, Maintenance, Solution, Investment, Ophthalmology, Growth, Carl-Zeiss-Stiftung, Technology, Acquisition, Foundation, GOM, Industry, Health, National Institute of Metrology Standardization and Industrial Quality, Plastic, Renewable energy, Telescopic sight

MAPLE GROVE, Minn., June 1, 2022 /PRNewswire/ -- Carl Zeiss Industrial Metrology, LLC will change their legal name to Carl Zeiss Industrial Quality Solutions, LLC on July 1, 2022, to reflect the growth and development of the company.

Key Points: 
  • MAPLE GROVE, Minn., June 1, 2022 /PRNewswire/ -- Carl Zeiss Industrial Metrology, LLC will change their legal name to Carl Zeiss Industrial Quality Solutions, LLC on July 1, 2022, to reflect the growth and development of the company.
  • ZEISS customers now benefit from their significantly expanded expertise and product portfolio with recent acquisitions of Bosello, GOM, and CAPTURE 3D.
  • In addition, ZEISS Industrial Quality Solutions offers a broad global spectrum of customer services with ZEISS Quality Excellence Centers close to its customers.
  • ZEISS Industrial Quality Solutions is part of the Industrial Quality & Research segment.

VirtaMed and Medical Microinstruments Partner to Advance the Skills of Surgeons Performing Complex Robotic Microsurgeries

Retrieved on: 
Thursday, May 26, 2022
Research, Technology, Medical Devices, Surgery, Hospitals, Other Technology, Software, Hardware, Health, Science, Spondyloarthropathy, Movement, Transoral laser microsurgery, Surgeon, Environment, Patient, Learning curve, Tremor, Solution, Virtual reality, ZEUS robotic surgical system, VR, MMI, Bandini s.p. 1000, Robotics, Instrument, Partnership, Adoption, Patient safety, Microsurgery, CEO, Dentistry, VirtaMed

Microsurgeries are a category of complex surgical procedures that focus on reconstructive surgery and require optical magnification, precision, and dexterity.

Key Points: 
  • Microsurgeries are a category of complex surgical procedures that focus on reconstructive surgery and require optical magnification, precision, and dexterity.
  • These VR-enabled simulations will allow surgeons to practice a variety of microsurgeries using the Symani robotic system and simulated surgical scenarios.
  • As robotic microsurgeries continue to grow, opportunities for advanced product development and training are essential to improve patient safety and outcomes.
  • This belief has guided our product and partnership approach since the company was formed, said Stefan Tuchschmid , Co-CEO at VirtaMed.

Medical Microinstruments Launches New Simulator for Robotic Microsurgery

Retrieved on: 
Thursday, May 26, 2022
Gynaecology, Spondyloarthropathy, VP, European Association of Urology, Surgeon, Multimedia, Patient, Tremor, Health, Solution, Association, MMI, Robotics, English, Elective surgery, Urology, Obstetrics, Marketing, Plastic, Technology, Ligation, Laparoscopy, Microsurgery, CEO, Medical device, Dentistry, Online shopping, VirtaMed

PISA, Italy, May 26, 2022 /PRNewswire/ -- Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced the launch of its Symani Surgical System Simulator developed by VirtaMed. The simulator will improve, expand, and digitize the pathways for Symani training as surgeons prepare to expand their microsurgical skills through robotics.

Key Points: 
  • PISA, Italy, May 26, 2022 /PRNewswire/ -- Medical Microinstruments (MMI) SpA , a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced the launch of its Symani Surgical System Simulator developed by VirtaMed.
  • The simulator will improve, expand, and digitize the pathways for Symani training as surgeons prepare to expand their microsurgical skills through robotics.
  • "By training on the simulator, surgeons will be even more prepared for their first Symani patient or for a challenging case."
  • Medical Microinstruments S.p.A. (MMI) was founded in 2015 near Pisa, Italy to enhance surgical performance through the development of a robotic system that enables surgeons to achieve better outcomes in microsurgery.

Medical Microinstruments Launches New Simulator for Robotic Microsurgery

Retrieved on: 
Thursday, May 26, 2022
Gynaecology, Spondyloarthropathy, VP, European Association of Urology, Surgeon, Patient, Tremor, Health, Solution, Association, MMI, Robotics, English, Elective surgery, Urology, Obstetrics, Marketing, Plastic, Technology, Ligation, Laparoscopy, Microsurgery, CEO, Medical device, Dentistry, Online shopping, VirtaMed

PISA, Italy, May 26, 2022 /PRNewswire/ -- Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced the launch of its Symani Surgical System Simulator developed by VirtaMed. The simulator will improve, expand, and digitize the pathways for Symani training as surgeons prepare to expand their microsurgical skills through robotics.

Key Points: 
  • PISA, Italy, May 26, 2022 /PRNewswire/ -- Medical Microinstruments (MMI) SpA , a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced the launch of its Symani Surgical System Simulator developed by VirtaMed.
  • The simulator will improve, expand, and digitize the pathways for Symani training as surgeons prepare to expand their microsurgical skills through robotics.
  • "By training on the simulator, surgeons will be even more prepared for their first Symani patient or for a challenging case."
  • Medical Microinstruments S.p.A. (MMI) was founded in 2015 near Pisa, Italy to enhance surgical performance through the development of a robotic system that enables surgeons to achieve better outcomes in microsurgery.

Medical Microinstruments Announces Major Expansion in Pisa, Italy to Support Growth

Retrieved on: 
Wednesday, May 18, 2022
Engineering, Spondyloarthropathy, VP, Surgeon, Patient, Tremor, MMI, Robotics, Research, Industry, Excellence, Communication, Center of excellence, Growth, Laboratory, Microsurgery, CEO, Hospital, Renewable energy, Dentistry

PISA, Italy, May 18, 2022 /PRNewswire/ -- Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced the grand opening of its new facility in Pisa, Italy.  MMI consolidated locations throughout the Pisa area into a 3,000m² singular site designed to accommodate company growth. The state-of-the-art facility will serve as the global 'Center of Excellence' for microsurgical surgical robotics, encompassing development, manufacturing, and administration. 

Key Points: 
  • PISA, Italy, May 18, 2022 /PRNewswire/ -- Medical Microinstruments (MMI) SpA , a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced the grand opening of its new facility in Pisa, Italy.
  • MMI consolidated locations throughout the Pisa area into a 3,000m singular site designed to accommodate company growth.
  • "Our new facility in Pisa marks the beginning of an exciting new era for MMI," said Mark Toland, CEO of MMI.
  • The Symani Surgical System combines proprietary innovations including the world's smallest wristed microinstruments as well as tremor-reducing and motion-scaling technologies.

Medical Microinstruments Announces Major Expansion in Pisa, Italy to Support Growth

Retrieved on: 
Wednesday, May 18, 2022
Engineering, Spondyloarthropathy, VP, Surgeon, Patient, Tremor, MMI, Robotics, Research, Industry, Excellence, Communication, Center of excellence, Growth, Laboratory, Microsurgery, CEO, Hospital, Renewable energy, Dentistry

PISA, Italy, May 18, 2022 /PRNewswire/ -- Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced the grand opening of its new facility in Pisa, Italy.  MMI consolidated locations throughout the Pisa area into a 3,000m² singular site designed to accommodate company growth. The state-of-the-art facility will serve as the global 'Center of Excellence' for microsurgical surgical robotics, encompassing development, manufacturing, and administration. 

Key Points: 
  • PISA, Italy, May 18, 2022 /PRNewswire/ -- Medical Microinstruments (MMI) SpA , a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced the grand opening of its new facility in Pisa, Italy.
  • MMI consolidated locations throughout the Pisa area into a 3,000m singular site designed to accommodate company growth.
  • "Our new facility in Pisa marks the beginning of an exciting new era for MMI," said Mark Toland, CEO of MMI.
  • The Symani Surgical System combines proprietary innovations including the world's smallest wristed microinstruments as well as tremor-reducing and motion-scaling technologies.

DGAP-News: Carl Zeiss Meditec achieves further significant growth in revenue and order intake in first half 2021/22

Retrieved on: 
Friday, May 13, 2022
Microsurgery, Research, Investment, Uncertainty, Tax, SBU, COVID-19, APAC, EMEA, Marketing, Sale, EBIT, Growth, Development, Animal

Order intake rose to an even greater extent than revenue, climbing 30.7% to 1,062.3m (prior year: 812.9m).

Key Points: 
  • Order intake rose to an even greater extent than revenue, climbing 30.7% to 1,062.3m (prior year: 812.9m).
  • I am therefore all the more delighted to be reporting these good half-year results an outstanding team achievement.
  • Order intake in the Microsurgery SBU likewise increased at a much higher rate than revenue.
  • The growth in revenue with a solid share of recurring revenue had a positive effect on this.